These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15650957)

  • 21. Early switch and early discharge opportunities in intravenous vancomycin treatment of suspected methicillin-resistant staphylococcal species infections.
    Parodi S; Rhew DC; Goetz MB
    J Manag Care Pharm; 2003; 9(4):317-26. PubMed ID: 14613450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstem R
    Clin Ther; 2007 Apr; 29(4):759-60; author reply 760-1. PubMed ID: 17617300
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection.
    Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G
    Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment with linezolid of septic shock secondary to methicillin-resistant Staphylococcus aureus arthritis.
    De Bels D; Garcia-Filoso A; Jeanmaire M; Préseau T; Miendje Deyi VY; Devriendt J
    J Antimicrob Chemother; 2005 May; 55(5):812-3. PubMed ID: 15743893
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis.
    Bounthavong M; Zargarzadeh A; Hsu DI; Vanness DJ
    Value Health; 2011; 14(5):631-9. PubMed ID: 21839399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drotrecogin alfa (activated) in South African private hospital ICUs.
    Hodgson RE; Williams PG; Foden AP; Grolman D
    S Afr Med J; 2003 Jul; 93(7):474-5. PubMed ID: 12939910
    [No Abstract]   [Full Text] [Related]  

  • 28. Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin.
    Gebhart BC; Barker BC; Markewitz BA
    Pharmacotherapy; 2007 Mar; 27(3):476-9. PubMed ID: 17316160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model.
    Conaughty JM; Chen J; Martinez OV; Chiappetta G; Brookfield KF; Eismont FJ
    Spine (Phila Pa 1976); 2006 Oct; 31(22):E830-2. PubMed ID: 17047530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
    Wegner DL
    MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Jacqueline C; Asseray N; Batard E; Le Mabecque V; Kergueris MF; Dube L; Bugnon D; Potel G; Caillon J
    Int J Antimicrob Agents; 2004 Oct; 24(4):393-6. PubMed ID: 15380267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Linezolid, coagulase-negative Staphylococcus and the problem of resistances].
    Rodríguez-Vidigal FF; Nogales-Muñoz N; Vera-Tomé A; Muñoz-Sanz A
    Med Clin (Barc); 2012 Nov; 139(12):553-4. PubMed ID: 22652016
    [No Abstract]   [Full Text] [Related]  

  • 35. [Resistance to linezolid in Staphylococcus aureus before its release].
    Akpabie A; Naga H; Giraud K; Al Rahiss R; Nadai S
    Pathol Biol (Paris); 2004 Oct; 52(8):493-6. PubMed ID: 15465271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
    Meka VG; Pillai SK; Sakoulas G; Wennersten C; Venkataraman L; DeGirolami PC; Eliopoulos GM; Moellering RC; Gold HS
    J Infect Dis; 2004 Jul; 190(2):311-7. PubMed ID: 15216466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
    Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL
    Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation after a notification policy of linezolid use: a case series of 22 patients.
    Ito W; Takeda M; Kayaba H; Ueki S; Sato K; Honda K; Kume M; Ishibashi K; Kobayashi N; Kagaya H; Fukui R; Watanabe E; Sakurada N; Tomita N; Chihara J
    J Chemother; 2009 Feb; 21(1):52-7. PubMed ID: 19297273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S
    Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
    Powers JH; Ross DB; Lin D; Soreth J
    Chest; 2004 Jul; 126(1):314-5; author reply 315-6. PubMed ID: 15249482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.